Day: August 20, 2020

Following the instructions of decision No. 241-19 dated 29 January 2018 on imposition of certain measures with respect to AB Snaigė, adopted of the Bank of Lithuania, on 19 August 2020 the amended Articles of Association of AB “Snaigė” (further – Company) was registered in the Register of Legal Entities. The authorized capital was reduced by EUR 3 566 015,55 by transferring this sum to revaluation reserve.After this change the authorized capital of the Company is EUR 6 735 807,15 (six million seven hundred thirty five thousand eight hundred seven euro and 15 eurocents). The nominal value of one share is EUR 0,17. The number of shares remained unchanged and is 39 622 395 pcs.   This change of authorized capital does not affect the Company’s financial results or solvency.Attached: Articles of Association of AB “Snaigė” registered...

Vykdant 2018 m. sausio 29 d. Lietuvos banko sprendimo Nr. 241-19 „Dėl poveikio priemonės taikymo AB „Snaigė“ nurodymus, 2020 m. rugpjūčio 19 d. Juridinių asmenų registre įregistruoti AB “Snaigė” (toliau – Bendrovė) pakeisti įstatai. Bendrovės įstatinis kapitalas sumažintas EUR 3 566 015,55, šią sumą pervedant į perkainojimo rezervą.Bendrovės įstatinis kapitalas po pakeitimų yra EUR 6 735 807,15 (šeši milijonai septyni šimtai trisdešimt penki tūkstančiai aštuoni šimtai septyni eurai ir 15 euro centų), Bendrovės vienos akcijos nominali vertė EUR 0,17. Bendrovės akcijų skaičius nesikeitė ir yra 39 622 395 vnt.Šis įstatinio kapitalo pokytis neįtakoja Bendrovės finansinių rezultatų bei mokumo.Pridedama: 2020 m. rugpjūčio 19 d. Juridinių asmenų registre įregistruoti AB „Snaigė“ įstatai.Generalinis direktorius Mindaugas SologubasTel. +370 315...

ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim™ Micro System for Treatment of Overactive Bladder, Fecal Incontinence and Non-Obstructive Urinary RetentionDUBLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has begun recruitment of the prospective, multicenter, global, post-market study of the InterStim™ Micro system for sacral neuromodulation (SNM) therapy. Medtronic announced approval from the U.S. Food and Drug Administration for the InterStim Micro neurostimulator on August 3, 2020, and CE Mark on January 13, 2020.“SNM therapy is already proven to be safe and effective, but we expect the ELITE study to definitively reinforce established SNM evidence in patients implanted with...

I forlængelse af den ordinære generalforsamling afholdt i Harboes Bryggeri A/S den 20. august 2020 skal det oplyses, at der efterfølgende blev afholdt konstituerende bestyrelsesmøde.Bestyrelsen konstituerede sig med Bernhard Griese som formand og Mads O. Krage som næstformand.Desuden konstituerede bestyrelsen sig i følgende udvalg:Revisionsudvalg: de generalforsamlingsvalgte bestyrelsesmedlemmer – Bernhard Griese, Mads O. Krage, Poul Møller, Claus Bayer, Bettina Køhlert og Ruth Schade, med sidst nævnte som formand.Vederlagsudvalg: Mads O. Krage, Bernhard Griese og Claus Bayer, med sidst nævnte som formand.Nomineringsudvalg: Bernhard Griese, Claus Bayer, Ruth Schade, og Bettina Køhlert, med sidst nævnte som formand.Bestyrelsen ser herefter ud som i vedlagte præsentation.Vedhæftet filHarboes bestyrelse

HINGHAM, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) — Following its participation at the Needham Virtual Med Tech & Diagnostic conference, as well as the overwhelming interest generated since its recent announcement which included the outcome of a feasibility animal study with respect to the LIBERTYTM Robotic System, Microbot Medical Inc. (Nasdaq: MBOT) will host a webinar on Wednesday, August 26, 2020 at 11:00am ET.  Harel Gadot, the Company’s CEO, President and Chairman, will share the Company’s view on the surgical robotic market, the results of the feasibility animal study, as well as other recent achievements. Additionally, members of the Company’s management team, including Dr. Eyal Morag, Chief Medical Officer, Simon Sharon, Chief Technology Officer and Eran Cohen, Senior Director of Business Development, will be available...

MCLEAN, Va., Aug. 20, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 2.99 percent.“Purchase housing demand continues to accelerate, ultimately providing support to an economy that otherwise has stagnated,” said Sam Khater, Freddie Mac’s Chief Economist. “The surge in sales led to a rapid increase in the demand for remodeling and home furnishings as consumers look to renovate while adjusting to home life during COVID.”News Facts30-year fixed-rate mortgage averaged 2.99 percent with an average 0.8 point for the week ending August 20, 2020, up from last week when it averaged 2.96 percent. A year ago at this time, the 30-year FRM averaged 3.55 percent.  15-year fixed-rate mortgage averaged 2.54 percent...

To Nasdaq Copenhagen20 August 2020Nykredit Realkredit A/S and Nykredit Bank A/S publish supplement to joint Euro Medium Term Note ProgrammeNykredit Realkredit A/S and Nykredit Bank A/S publish supplement dated 20 August 2020 to joint €10,000,000,000 Euro Medium Term Note Programme (“EMTN Programme”) dated 13 May 2020.Under the EMTN Programme Nykredit Realkredit may issue Subordinated Notes (Tier 2 or Tier 2 Contingent Capital Notes), Senior Non-Preferred Notes and Senior Unsecured Notes. Nykredit Bank may issue Senior Unsecured Notes.The supplement and the EMTN Programme are available for download on Nykredit’s website at nykredit.com/ir.Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21 or Kristian Ingemann Petersen, Attorney-at-Law, tel +45 44 55 16 78.AttachmentsNykredit...

To Nasdaq Copenhagen20 August 2020Nykredit Realkredit A/S and Nykredit Bank A/S publish supplement to joint Euro Medium Term Note ProgrammeNykredit Realkredit A/S and Nykredit Bank A/S publish supplement dated 20 August 2020 to joint €10,000,000,000 Euro Medium Term Note Programme (“EMTN Programme”) dated 13 May 2020.Under the EMTN Programme Nykredit Realkredit may issue Subordinated Notes (Tier 2 or Tier 2 Contingent Capital Notes), Senior Non-Preferred Notes and Senior Unsecured Notes. Nykredit Bank may issue Senior Unsecured Notes.The supplement and the EMTN Programme are available for download on Nykredit’s website at nykredit.com/ir.Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21 or Kristian Ingemann Petersen, Attorney-at-Law, tel +45 44 55 16 78.AttachmentsNykredit...

Rekstrarniðurstaða samstæðu Kópavogsbæjar, A og B hluta, var neikvæð um 443 milljónir króna á fyrri hluta ársins 2020. Áætlun ársins gerði ráð fyrir rekstrarhalla að upphæð 75 milljónum króna fyrstu sex mánuði ársins á samstæðunni, en 597 milljón króna afgangi á árinu öllu, enda falla tæpur helmingur skatttekna til á fyrri hluta árs en stærri hluti útgjalda á ákveðnum sviðum. Heildarskuldir samstæðunnar lækkuðu á fyrri helmingi árs um 210 milljónir meðal annars vegna uppgreiðslu á óhagkvæmum lánum.Þetta kemur fram í óendurskoðuðum árshlutareikningi Kópavogs fyrir 1. janúar til 30. júní 2020 sem lagður hefur verið fram í bæjarráði Kópavogs.Skýring mismunar á áætlun og niðurstöðu rekstrarniðurstöðu samstæðunnar er tekjufall vegna COVID-19. Þar má nefna að útsvarstekjur eru lægri en gert var ráð fyrir, sundlaugar voru lokaðar hluta tímabilsins...

AB Linas Agro Group received the notifications from Darius Zubas and Dainius Pilkauskas  about changes in voting rights (see attachments).For more information please contact Finance Director Mažvydas Šileika, mob.  +370 619 19 403, e-mail m.sileika@linasagro.lt.AttachmentsNotification on the changes of the voting rights_Darius ZubasNotification on the disposal of the voting rights_Dainius_Pilkauskas